Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Cytosorbents (CTSO) Leases (2018 - 2025)

Cytosorbents (CTSO) has disclosed Leases for 8 consecutive years, with $11.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases fell 4.95% year-over-year to $11.1 million, compared with a TTM value of $11.1 million through Sep 2025, down 4.95%, and an annual FY2024 reading of $11.5 million, down 4.54% over the prior year.
  • Leases was $11.1 million for Q3 2025 at Cytosorbents, down from $11.2 million in the prior quarter.
  • Across five years, Leases topped out at $13.7 million in Q3 2021 and bottomed at $923960.0 in Q1 2021.
  • Average Leases over 5 years is $11.7 million, with a median of $12.2 million recorded in 2023.
  • Peak annual rise in Leases hit 1328.29% in 2022, while the deepest fall reached 6.28% in 2022.
  • Year by year, Leases stood at $13.4 million in 2021, then decreased by 6.11% to $12.6 million in 2022, then decreased by 4.32% to $12.1 million in 2023, then dropped by 4.54% to $11.5 million in 2024, then fell by 3.79% to $11.1 million in 2025.
  • Business Quant data shows Leases for CTSO at $11.1 million in Q3 2025, $11.2 million in Q2 2025, and $11.4 million in Q1 2025.